News and Announcements
YPB to Acquire nTouch to Leverage Outstanding B2B Consumer Engagement Opportunity
- Published August 26, 2015 4:40PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th August 2015, ASX Announcement
Highlights:
- YPB to acquire proximity marketing & B2C engagement technology company nTouch with high profile investors including cricket hall of fame inductee Steve Waugh
- Excellent product and path to revenue synergies
- nTouch to provide additional distribution channels within Australia, India & USA
- $4.5 million scrip acquisition based on YPB share price of $0.35
Anti-counterfeiting technology company YPB Group Limited (ASX:YPB)has signed a letter of intent to acquire all the issued shares of proximity marketing technology company nTouch Holding Pty Ltd (“nTouch”).
Under all the scrip acquisition nTouch will be issued $4.5 million in fully paid ordinary shares of YPB at $0.35 per share. The newly issued shares will be subject to voluntary escrow on term to be agreed.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
